 |
市場調查報告書
商品編碼
1671963
纖維肌痛治療市場：按分銷管道和地區分類Fibromyalgia Treatment Market,, By Distribution Channel, By Geography |
||||||
價格
簡介目錄
2025 年全球纖維肌痛治療市場規模估計為 31.8 億美元，預計到 2032 年將達到 40.5 億美元，2025 年至 2032 年的複合年成長率為 3.5%。
| 報告範圍 | 報告詳細資訊 | ||
|---|---|---|---|
| 基準年 | 2024 | 2025 年市場規模 | 31.8億美元 |
| 效能資料 | 從 2020 年到 2024 年 | 預測期 | 2025 至 2032 年 |
| 預測期：2025-2032年複合年成長率： | 3.50％ | 2032 年價值預測 | 40.5億美元 |
數字。 2025 年纖維肌痛治療市場佔有率（按地區分類）
纖維肌痛症是一種以肌肉、韌帶和肌腱的慢性廣泛性疼痛和壓痛為特徵的疾病。它常伴隨疲勞、睡眠障礙、記憶問題和情緒障礙。纖維肌痛的具體病因尚不清楚，但人們認為它是由大腦的神經化學失衡引起的。這些症狀會對患者的生活品質產生負面影響。目前，纖維肌痛尚無治癒方法，但治療旨在控制症狀和改善日常功能。常見的治療方法包括藥物治療、改變生活方式、替代療法和認知行為療法。由於診斷率上升和對疾病意識的提高，全球纖維肌痛治療市場預計將顯著成長。
市場動態：
全球纖維肌痛治療市場受到全球纖維肌痛盛行率上升的推動。據估計，纖維肌痛影響著全球約 2-8% 的人口。此外，用於治療纖維肌痛的新藥物配方的核准越來越多，也推動了市場的成長。然而，高昂的治療費用和缺乏成熟的治療方法阻礙了市場潛力。另一個問題是醫生缺乏意識。市場先驅有機會開發治療纖維肌痛的新配方並提供經濟實惠的治療選擇。生物製藥的日益普及也將開闢新的成長途徑。
本研究的主要特點
- 本報告對全球纖維肌痛治療市場進行了詳細分析，並給出了預測期（2025-2032 年）的市場規模（BN$）和年複合成長率（CAGR%），假設 2024 年為基準年。
- 它還強調了各個領域的潛在商機並說明了該市場的有吸引力的投資提案矩陣。
- 它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。
- 全球纖維肌痛治療市場的主要企業已根據公司亮點、產品系列、關鍵亮點、財務績效和策略等參數進行了分析。
- 本報告的見解將使負責人和企業經營團隊能夠就未來產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
- 全球纖維肌痛治療市場報告針對該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
- 相關人員將透過用於分析全球纖維肌痛治療市場的各種策略矩陣更輕鬆地做出決策。
目錄
第1章 調查目的與前提條件
- 研究目標
- 先決條件
- 簡稱
第2章 市場展望
- 報告描述
- 市場定義和範圍
- 執行摘要
- Coherent Opportunity Map（COM）
第3章市場動態、法規與趨勢分析
- 市場動態
- 驅動程式
- 限制因素
- 市場機會
- 影響分析
- 管道分析
- 專利訴訟
- 贖回
- 專利格局（ANDA/NDA Intelligence）
- PEST分析
- 波特的分析
4. 全球纖維肌痛治療市場 - 冠狀病毒 (COVID-19) 大流行的影響
- 整體影響
- 政府舉措
- COVID-19 市場影響
5. 2020 年至 2032 年全球纖維肌痛治療市場（按藥物類別分類）（十億美元）
- 抗憂鬱症
- 抗驚厥藥
- 肌肉鬆弛劑
- 止痛藥
- 其他
6. 2020-2032 年全球纖維肌痛治療市場按分銷管道分類（十億美元）
- 醫院藥房
- 零售藥局
- 網路藥局
7. 2020 年至 2032 年全球纖維肌痛治療市場（按地區分類）（十億美元）
- 北美洲
- 拉丁美洲
- 歐洲
- 亞太地區
- 中東
- 非洲
第8章 競爭格局
- 熱圖分析
- 公司簡介
- Eli Lilly and Company
- Pfizer, Inc.
- Novartis AG
- Allergan plc
- Sun Pharmaceutical Industries Ltd.
- Aptinyx, Inc.
- Prismic Pharmaceuticals, Inc.
- Innovative Med Concepts, Inc.
- Intec Pharma Ltd
- Astellas Pharma Inc.
- Johnson &Johnson
- GSK
- AstraZeneca plc
- Bristol Myers Squibb
- Viatris
- Takeda Pharmaceutical Company Limited
- Amgen Inc.
- Sanofi
第 9 章 分析師觀點
第10章參考文獻與調查方法
- 參考
- 調查方法
簡介目錄
Product Code: CMI1691
Global Fibromyalgia Treatment Market is estimated to be valued at USD 3.18 Bn in 2025 and is expected to reach USD 4.05 Bn by 2032, growing at a compound annual growth rate (CAGR) of 3.5% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 3.18 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 3.50% | 2032 Value Projection: | USD 4.05 Bn |
Figure. Fibromyalgia Treatment Market Share (%), By Region 2025
Fibromyalgia is a disorder characterized by chronic widespread pain and tenderness in the muscles, ligaments and tendons. It is often accompanied by fatigue, sleep issues, memory and mood issues. The exact cause of fibromyalgia is still unknown but is believed to be due to neurochemical imbalance in the brain. The symptoms negatively impact quality of life of those suffering from it. Currently there is no cure for fibromyalgia but the treatment aims to manage symptoms and improve day to day functioning. Some of the common treatment options include medications, lifestyle changes, alternate therapies, cognitive behavior therapy etc. The global fibromyalgia treatment market is expected to witness significant growth due to the increasing diagnosis rates and growing awareness about the condition.
Market Dynamics:
The global fibromyalgia treatment market is driven by the rising prevalence of fibromyalgia worldwide. As per estimates, fibromyalgia affects about 2-8% of the global population. Moreover, increasing approval of new drug formulations for fibromyalgia treatment is also boosting the market growth. However, high cost of treatment therapies and lack of cure hinders the market potential. Lack of awareness among physicians also poses a challenge. The market players have opportunities to develop novel drug formulations for fibromyalgia cure and offer treatment options at affordable prices. Increasing adoption of biologics also opens new growth avenues.
Key Features of the Study:
- This report provides in-depth analysis of the global fibromyalgia treatment market, and provides market size (USD BN) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global fibromyalgia treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study includes Eli Lilly and Company, Pfizer Inc., Novartis AG, Allergan plc, Sun Pharmaceutical Industries Ltd., Aptinyx Inc., Prismic Pharmaceuticals Inc., Innovative Med Concepts Inc., Intec Pharma Ltd., Astellas Pharma Inc., Johnson & Johnson, GSK, AstraZeneca plc, Bristol Myers Squibb, Viatris, Takeda Pharmaceutical Company Limited, Amgen Inc., and Sanofi.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global fibromyalgia treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global fibromyalgia treatment market.
Market Segmentation
- Drug Class:
- Antidepressants
- Antiepileptics
- Muscle Relaxants
- Analgesics
- Others
- Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Regional:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- Eli Lilly and Company
- Pfizer Inc.
- Novartis AG
- Allergan plc
- Sun Pharmaceutical Industries Ltd.
- Aptinyx Inc.
- Prismic Pharmaceuticals Inc.
- Innovative Med Concepts Inc.
- Intec Pharma Ltd.
- Astellas Pharma Inc.
- Johnson & Johnson
- GSK
- AstraZeneca plc
- Bristol Myers Squibb
- Viatris
- Takeda Pharmaceutical Company Limited
- Amgen Inc.
- Sanofi
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Drug Class
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Pipeline Analysis
- Patent Litigations
- Reimbursement
- Patent Landscape (ANDA/NDA Intelligence)
- PEST Analysis
- Porter's Analysis
4. Global Fibromyalgia Treatment Market- Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the market
5. Global Fibromyalgia Treatment Market, By Drug Class, 2020 - 2032, (USD BN)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
- Antidepressants
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
- Segment Trends
- Antiepileptics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
- Segment Trends
- Muscle Relaxants
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
- Analgesics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
6. Global Fibromyalgia Treatment Market, By Distribution Channel, 2020 - 2032, (USD BN)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
- Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
- Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
- Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
7. Global Fibromyalgia Treatment Market, By Region, 2020 - 2032, (USD BN)
- Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Regions, 2020-2032
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD BN)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD BN)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD BN)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD BN)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD BN)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD BN)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Heat Map Analysis
- Company Profiles
- Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Pfizer, Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Market Strategies
- Novartis AG
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Market Strategies
- Allergan plc
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Market Strategies
- Sun Pharmaceutical Industries Ltd.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Market Strategies
- Aptinyx, Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Market Strategies
- Prismic Pharmaceuticals, Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Market Strategies
- Innovative Med Concepts, Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Market Strategies
- Intec Pharma Ltd
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Market Strategies
- Astellas Pharma Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Market Strategies
- Johnson & Johnson
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Market Strategies
- GSK
- AstraZeneca plc
- Bristol Myers Squibb
- Viatris
- Takeda Pharmaceutical Company Limited
- Amgen Inc.
- Sanofi
- Eli Lilly and Company
9. Analyst View
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
10. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
